Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy
Open Access
- 2 December 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 362
Abstract
Multipotential mesenchymal stromal cells (MSC) are present as a rare subpopulation within any type of stroma in the body of higher animals. Prominently, MSC have been recognized to reside in perivascular locations, supposedly maintaining blood vessel integrity. During tissue damage and injury, MSC/pericytes become activated, evade from their perivascular niche and are thus assumed to support wound healing and tissue regeneration. In vitro MSC exhibit demonstrated capabilities to differentiate into a wide variety of tissue cell types. Hence, many MSC-based therapeutic approaches have been performed to address bone, cartilage or heart regeneration. Furthermore, prominent studies showed efficacy of ex vivo expanded MSC to countervail graft-versus-host-disease. Therefore, additional fields of application are presently conceived, in which MSC-based therapies potentially unfold beneficial effects, such as amelioration of non-healing conditions after tendon or spinal cord injury, as well as neuropathies. Working along these lines, MSC-based scientific research has been forged ahead to prominently occupy the clinical stage. Aging is to a great deal stochastic by nature bringing forth changes in an individual fashion. Yet, is aging of stem cells or/and their corresponding niche considered a determining factor for outcome and success of clinical therapies?Keywords
Funding Information
- the European Union's Seventh Framework Program (FP7-SSH-2012-1, 320333)
This publication has 148 references indexed in Scilit:
- Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cellsBMC Medicine, 2013
- Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free MediumStem Cells International, 2013
- Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation PotentialStem Cell Reviews and Reports, 2012
- Human Blood-Vessel-Derived Stem Cells for Tissue Repair and RegenerationJournal of Biomedicine and Biotechnology, 2012
- Tissue Distribution of Mesenchymal Stem Cell Marker Stro-1Stem Cells and Development, 2011
- Mesenchymal stem cell marker Stro-1 is a 75kd endothelial antigenBiochemical and Biophysical Research Communications, 2011
- Dual origin of mesenchymal stem cells contributing to organ growth and repairProceedings of the National Academy of Sciences, 2011
- Defining Stem and Progenitor Cells within Adipose TissueStem Cells and Development, 2008
- Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditionsCytotechnology, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006